News

BioDelivery Sciences International, Inc., a specialty pharmaceutical company with a focus in pain management and addiction medicine, and Purdue Pharma (Canada) announce that they have…
Read More...

Abzena plc, the life sciences group providing services and technologies to enable the development and manufacture of biopharmaceutical products, has signed a licensing agreement and a…
Read More...

CURE Pharmaceutical, a leading disruptive drug delivery technology and pharmaceutical cannabinoid molecule development company and Therapix Biosciences, a specialty clinical-stage…
Read More...

InMed Pharmaceuticals, Inc., a biopharmaceutical company specializing in the research and development of novel, cannabinoid-based drug therapies, is pleased to announce it has entered…
Read More...

Eurofins Scientific, a global leader in bio-pharmaceutical products testing, and one of the world leaders in genomic services, announces that it has signed an exclusive agreement with…
Read More...

Zydus announced the initiation of a phase II trial investigating ZYAN1, an oral hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI), as a treatment for anemia associated…
Read More...

Swedish Orphan Biovitrum has been granted Orphan Drug Designation (ODD) by the U.S. Food and Drug Administration (FDA) for the company’s development candidate SOBI003, a chemically…
Read More...

Exscientia, an innovative company at the forefront of Artificial Intelligence (AI)-driven drug discovery, is pleased to announce it has entered into a strategic drug discovery…
Read More...

Sun Pharma and Samsung BioLogics announced a strategic long-term manufacturing agreement for Tildrakizumab. The agreement was entered into by Sun Pharma's wholly-owned subsidiary and…
Read More...

Endo International plc announced that it has completed the previously announced divestiture of its South African based operations, Litha Healthcare Group, to Acino Pharma AG. In…
Read More...

Arbor Pharmaceuticals, LLC, a U.S.-based specialty pharmaceutical company, and Debiopharm International SA, part of Debiopharm Group™, a Swiss-based global biopharmaceutical company,…
Read More...

CordenPharma International and GE Healthcare’s Dharmacon business have entered a strategic collaboration to create an end-to-end solution for oligonucleotide-based drug discovery.…
Read More...

Valeant Pharmaceuticals announced that its affiliate has completed the sale of all of the outstanding equity interests in its former subsidiary Dendreon Pharmaceuticals LLC to the…
Read More...

Trovagene, a precision medicine biotechnology company, announced it has executed a supplier agreement with NerPharMa, S.r.l., a pharmaceutical manufacturing company and a subsidiary of…
Read More...

Glytec, the healthcare company behind a market-leading software solution for personalized diabetes therapy management, announces five new patent allowances for its eGlycemic Management…
Read More...

Bioverativ announced that it has successfully completed its acquisition of True North Therapeutics, a privately-held, clinical-stage rare disease biotechnology company. The acquisition…
Read More...

LivaNova announced that it received FDA approval of its VNS Therapy system in patients as young as four years of age with partial onset seizures that are refractory to antiepileptic…
Read More...

Casebia Therapeutics, the joint venture founded by Bayer and CRISPR Therapeutics, announced the hiring of Robin A. Walker as the company’s Vice President, Head of Legal. Walker is a…
Read More...

Veeva Systems announced that Santhera Pharmaceuticals selected Veeva CRM and Veeva OpenData as a commercial software and data platform for its first product launch. The rare disease…
Read More...

LifeArc, the UK medical research charity previously known as MRC Technology, The Centre for Drug Research and Development (CDRD), and the Defence Science and Technology Laboratory…
Read More...